Sensitivity and Specificity of Cetuximab-IRDye800 to Identify Regional Metastatic Disease in Patients with Head and Neck Cancer


  • Lindsay S. Moore, MD; Jason M. Warram, PhD; Thomas K. Chung, MD; Esther de Boer, BSc; William R. Carroll, MD; Eben L. Rosenthal, MD

Presented at these meetings:


  • No PDF available.

The Laryngoscope and ENTtoday are published by Wiley on behalf of the Triological Society.